Tian'an Pharmaceutical Co., Ltd. (TNPH)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.02 Thousand | -14.03 Thousand | -26.21 Thousand | -78.71 Thousand | -87.59 Thousand | 18.19 Thousand |
| Net Income | -16.02 Thousand | -20.44 Thousand | -31.39 Thousand | -80.07 Thousand | -114.15 Thousand | -22.72 Thousand |
| Depreciation & Amortization | 153.00 | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -522.00 | 6411.00 | 5176.00 | 1356.00 | 26.55 Thousand | -79.00 |
| Other non-cash items | 353.85 Thousand | 86.00 | -417.00 | 157.00 | -14.33 Thousand | 41.07 Thousand |
| Investing Cash Flow | - | - | - | - | - | -19.7 Thousand |
| Investments in PPE | 4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -19.7 Thousand |
| Financing Cash Flow | 13.45 Thousand | 6428.00 | 20.98 Thousand | 78.71 Thousand | 102.59 Thousand | 1505.00 |
| Debt repayment | -133.15 Thousand | -6428.00 | -20.98 Thousand | -33.71 Thousand | -120.86 Thousand | -1505.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -18.27 Thousand | - |
| Common Stock Issuance | 146.6 Thousand | - | - | 45 Thousand | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -332.22 Thousand | -86.00 | 417.00 | -157.00 | 14.33 Thousand | -79.00 |
| Accounts payables | 349.65 Thousand | 6497.00 | - | - | - | - |
| Inventory | -17.95 Thousand | -6497.00 | - | - | - | - |
| Other working capital | 349.65 Thousand | 6497.00 | 4759.00 | 1513.00 | 12.22 Thousand | - |
| Cash at beginning of period | 2151.00 | 107.18 Thousand | 15 Thousand | 15 Thousand | - | - |
| Cash at end of period | 2577.00 | 2151.00 | 107.18 Thousand | 15 Thousand | 15 Thousand | - |
| Capital Expenditure | 4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 426.00 | -105.02 Thousand | 92.18 Thousand | - | 15 Thousand | - |
| Free Cash Flow | -13.02 Thousand | -14.03 Thousand | -26.21 Thousand | -78.71 Thousand | -87.59 Thousand | 18.19 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2985.00 | -5828.00 | 38.57 Thousand | -16.02 Thousand | -43.87 Thousand | -1664.00 |
| Depreciation & Amortization | - | - | 153.00 | 153.00 | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2940.00 | 3440.00 | -44.89 Thousand | -522.00 | 40.49 Thousand | -4947.00 |
| Other non-cash items | -1440.00 | 903.00 | 325.01 Thousand | 353.85 Thousand | 4388.00 | -1632.00 |
| Investing Cash Flow | - | - | 44.00 | - | - | -44.00 |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | 44.00 | - | - | -44.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 5610.00 | 13.45 Thousand | 1274.00 | 6566.00 |
| Debt repayment | - | - | -140.99 Thousand | -133.15 Thousand | -1274.00 | -6566.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 146.6 Thousand | 146.6 Thousand | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 1440.00 | 1440.00 | -313.16 Thousand | -332.22 Thousand | -12.63 Thousand | 1632.00 |
| Accounts payables | - | - | 286.22 Thousand | 349.65 Thousand | - | - |
| Inventory | - | - | - | -17.95 Thousand | - | - |
| Other working capital | 1500.00 | 2000.00 | 286.22 Thousand | 349.65 Thousand | 53.13 Thousand | -6579.00 |
| Cash at beginning of period | 263.00 | 2577.00 | 171.31 Thousand | 2151.00 | 2048.00 | 2137.00 |
| Cash at end of period | 218.00 | 263.00 | 2577.00 | 2577.00 | 171.31 Thousand | 2048.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -179.77 Thousand | - | - | - |
| Net cash flow / Change in cash | -45.00 | -2314.00 | -168.73 Thousand | 426.00 | 169.26 Thousand | -89.00 |
| Free Cash Flow | -45.00 | -45.00 | 5383.00 | -13.02 Thousand | -11.62 Thousand | -6611.00 |
0IRE
ENRG
GAYGF
PLIN
1558
CARM